Capital Fund Management (CFM)
PRAX icon

Capital Fund Management (CFM)’s Praxis Precision Medicines PRAX Stock Holding History

Capital Fund Management (CFM)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.06M Buy
+27,058
New +$8.57M 0.04% 636
2025
Q3 		– Sell
-24,292
Closed -$1.02M – 2639
2025
Q2 		$1.02M Buy
+24,292
New +$925K ﹤0.01% 1995

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Capital Fund Management (CFM)'s PRAX Position: Q2 2026 in Review

Capital Fund Management (CFM) opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 27,058 shares worth $9.06M. The stake represents 0.04% of the portfolio and ranks #636 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in PRAX as recently as Q2 2025.

Capital Fund Management (CFM) first reported a position in PRAX in Q2 2025 and has held it in 2 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Capital Fund Management (CFM) held 27,058 shares of Praxis Precision Medicines worth $9.06M as of Q2 2026.
  • Praxis Precision Medicines was a new Capital Fund Management (CFM) position in Q2 2026.
  • Praxis Precision Medicines made up 0.04% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #636 holding.
  • Capital Fund Management (CFM) first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 2 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.